Q3 U.S. venture capital financing announcement in 2020 What are the new trends in the medical and health sectors?

CB Insights and PwC recently released MoneyTree Report for Q3 2020, which provides an inventory and analysis of funding for VC and startups in the third quarter of 2020. 1. In the third quarter of 2020, U.S. start-ups financed $36.5 billion through venture capital, the second-highest total in history and second only to the fourth quarter of 2018.
into different areas, with 271 financing incidents completed in the pharmaceutical and health sector in the last quarter, with a total financing quota of US$8 billion.
the number of financing events and the total amount of financing ranked 2nd.
the overall financing in the field of medical and pharmaceutical health is active.
The sum and total financing of corporate finance incidents in various industries in Q3 2020 (Photo: PwC/CB Insights MoneyTree Report Q3 2020) 2. Large financing events continue, and potential new industry centers deserve attention from the point of view of the amount of single total financing, the pharmaceutical and health sector also generated a lot of heavy financing events in the third quarter of 2020.
of all mergers and acquisitions, Illumina's $8 billion valuation of graIL, a cancer early-screening company, was the most highly valued acquisition in the third quarter of 2020.
IPO boom continues: as of the third quarter, the total number of pharmaceutical companies completing IPOs this year has exceeded the total number of IPOs in 2019, with multiple IPOs raising more than $100 million.
Oak Street Health became the fifth largest company in total IPO financing in the third quarter of 2020 with a $500 million financing.
boston area and the San Francisco Bay Area have been two of the largest health industry centers in the United States.
From the third quarter of 2020 financing in different regions: Four of the top five companies in Minneapolis and Texas are pharmaceutical companies, and two of the top 3 companies in Dallas are pharmaceutical companies.
whether these areas can become the new medical and health industry center in the future is worth paying attention to.
The top five companies in Minneapolis total financing in Q3 2020 (Photo: PwC/CB Insights MoneyTree Report Q3 2020) 3. Three of the four emerging areas covered by pharmaceutical companies by classifying start-up financing areas in the third quarter of 2020, the report summarizes 20 emerging sectors.
the top four sectors showed good growth momentum in digital healthcare, fintech, artificial intelligence and medical devices.
addition to fintech, three of the four emerging sectors with good growth momentum are closely related to pharmaceutical companies.
, four of the top five companies in total financing in the field of artificial intelligence have core businesses closely linked to the pharmaceutical and health industries.
The analysis of the report by PwC/CB Insights MoneyTree Report Q3 Q3 2020 shows that the pharmaceutical sector is at a high-speed stage of development, with capital attention, while also showing many new directions.
with the help of capital, patients can enjoy better medical services and treatment conditions as soon as possible.
Resources: s1 US MoneyTree Reporting: Q3 2020. Retrieved October 22, 2020, from.